NCT02988778View on ClinicalTrials.gov

Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 8, 2019

Primary Completion Date

October 8, 2019

Study Completion Date

October 8, 2019

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Budesonid 50mcg (Noex)

Suspention to nasal use, 2 atomization in each nostril during the morning and at night.

DRUG

Budesonid 50mcg (Busonid)

Suspention to nasal use, 2 atomization in each nostril during the morning and at night.

Trial Locations (1)

Unknown

Alexandra Dumont, Campinas

Sponsors
All Listed Sponsors
lead

Eurofarma Laboratorios S.A.

INDUSTRY